Superoxide dismutase (SOD) for mustard gas burns

Burns

Volumn 24, Issue 2, 1998, Pages 114-119

  Eldad, Arieh ^a   Meir, Patrik Ben ^a   Breiterman, Semion ^a   Chaouat, Malka ^a   Shafran, Aaron ^b   Ben Bassat, Hannah ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; MUSTARD GAS; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLISTER; BURN; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GUINEA PIG; HISTOPATHOLOGY; INFECTION PREVENTION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; SKIN DEFECT; TOPICAL DRUG ADMINISTRATION;

ANIMALS; BIOPSY; BURNS, CHEMICAL; CHEMICAL WARFARE AGENTS; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; GUINEA PIGS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAPERITONEAL; MUSTARD GAS; SKIN; SKIN DISEASES; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; WOUND HEALING;

EID: 0032029304     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(97)00085-5     Document Type: Article

References (12)

1. [1] Warthin A. S., Weller C. V. The Medical Aspects of Mustard Gas Poisoning. Henry Kimpton, London, 1919.
2. [2] Willems, J. L., Clinical management of mustard gas casualties. Annal. Med. Milit. Belg., 1989, 3 (suppl.), 1-61.
3. [3] Mellor, S. G., Rice, P. and Cooper, G. C., Vesicant burns. Br. J. Plast. Surg., 1991, 44 (6), 434-437.
4. [4] Momeni, A. Z., Enshaeih, S., Meghadadi, M. and Amindjavaheri, M., Skin manifestations of mustard gas: A clinical study of 535 patients exposed to mustard gas. Arch. Dermatol., 1992, 128, 775-780.
5. [5] Gross, C. L., Meier, H. L., Papirmeister, B., Brinkley, F. B. and Johnson, J. B., Sulfur mustard lowers nicotinamide adenine dinucleotide concentrations in human skin grafted to nude mice. Toxicol. Appl. Pharmacol., 1985, 81 (1), 85-90.
6. [6] Wooliscroft, J. O., Prasad, J. K. and Thomson, P. D. et al., Metabolic alterations in burn patients: detection of adenosin triphosphate degradation products and lipid peroxides. Burns, 1990, 16, 92-96.
7. [7] Hiramatsu, M. and Izawa, Y., Serum lipid peroxidase levels of patients suffering thermal injury. Burns, 1984, 11, 111-118.
8. [8] Till, G. O., Hatherill, J. R. and Tourtellotte, W. W. et al., Lipid peroxidation and acute lung injury after thermal trauma to skin. Am. J. Pathol., 1985, 119, 376-384.
9. [9] Johnson, K. J. and Ward, P. A., Role of oxygen metabolites in immune complex injury of lung. J. Immunol., 1981, 126, 2365-2371.
10. [10] Till, G. O., Beauchamp, C., Menapace, D., Tourtellotte, W., Kunkel, R., Johnson, K. J. and Ward, P. A., Oxygen radical-dependent lung injury following thermal injury of rat skin. Trauma, 1983, 23, 269-277.
11. [11] McCormick, J. R., Harkin, M. M. and Johnson, K. J. et al., Suppression by superoxide dismutase of immune-complex-induced pulmonary alveolitis and dermal inflammation. Am. J. Pathol., 1981, 102, 55-64.
12. [12] Eldad, A., Wisoki, M., Cohen, H., Breiterman, S., Chaouat, M., Wexler, W. R. and Ben-Bassat, H., Phosphorus burns: evaluation of various modalities for primary treatment. J. Burn Care Rehab., 1995, 16, 49-55.